NanoCHIP® XL Analyzer
The NanoChip® system is an automated, multi-purpose instrument which is used for clinical molecular diagnostics. Clinical microbiology, genetics/cytogenetics and pathology laboratories use this convenient platform to identify pathogenic infections, carriage of genetic disorders, predisposition to diseases and response to pharmaceutical therapies. The NanoCHIP® technology is intended for those users that require: Medium-to…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The NanoChip® system is an automated, multi-purpose instrument which is used for clinical molecular diagnostics. Clinical microbiology, genetics/cytogenetics and pathology laboratories use this convenient platform to identify pathogenic infections, carriage of genetic disorders, predisposition to diseases and response to pharmaceutical therapies.
The NanoCHIP® technology is intended for those users that require:
- Medium-to high throughput
- Multiplex molecular testing (over 4 markers/sample)
- Automation
- Simplicity
- Full LIS connectivity
Evaluation of the First Microarray-Based Molecular Screening Test for Eight Gastrointestinal Pathogens Using the Automated NanoCHIP Platform
Gastroenteritis is a challenging syndrome to diagnose clinically and microbiologically. The Savyon Gastrointestinal Panel (GIP) is a block-based multiplex nucleic acid amplification test (NAAT) that detects eight enteric pathogens. The objective of this study was to assess the analytical sensitivity of the GIP assay and to compare the detection capability of the Savyon GIP for diarrhoeal samples positive by conventional methods (culture/microscopy/ELISA).
A Novel Molecular-Based Diagnostic Screening Test Utilizing the NanoCHIP® Microarray Technology for Simultaneous Detection of Major STI’s
Sexually transmitted infections (STI) are widely abundant all over the world, and there is a need for detection of early stages of STIs is in order to control and prevent these diseases. This study, presented at ECCMID 2014, demonstrates the utility of a newly developed test for screening purposes of STIs especially in high-risk populations.
Validation of a New DNA Extraction Method from Agar or Liquid Swabs for Molecular Detection of MRSA, VRE and KPC Utilizing the NanoCHIP® Microarray Technology
Hospital acquired infections can be widely prevented through screening of patients before or during hospital admission, and proper patient isolation and management. This study, presented at ECCMID 2014, demonstrates the compatibility of different swabs, with new PCR - NanoCHIP® technology for screening large number of samples for simultaneous detection of MRSA, VRE and KPC in variety of clinical samples.
Novel NanoCHIP® XL-Based Molecular Tests For Screening and Genotyping The Most Abundant Human Papillomavirus High- and Low-Risk Strains
Savyon Diagnostics is engaged with development of the concept of two separate and consecutive molecular-based tests, i.e. screening and genotyping of HPV high- and low-risk strains on the NanoCHIP®XL molecular electronic microarray system. This poster demonstrates the usefulness of the newly developed tests in providing a comprehensive solution to the need for efficient screening, early detection and HPV genotyping.
